QI Project Reduces Unnecessary Peds Inpatient Electrolyte Testing

Share this content:
QI Project Reduces Unnecessary Peds Inpatient Electrolyte Testing
QI Project Reduces Unnecessary Peds Inpatient Electrolyte Testing

WEDNESDAY, April 4, 2018 (HealthDay News) -- A quality improvement initiative rapidly reduced unnecessary electrolyte testing among hospitalized pediatric patients, according to a study published online April 4 in Pediatrics.

Michael J. Tchou, M.D., from the Cincinnati Children's Hospital Medical Center, and colleagues conducted a quality improvement project targeting use of electrolyte testing among six hospital medicine teams in a large academic children's hospital system. Using the Model for Improvement, interventions included standardizing communication about the plan and education about the costs and risks associated with overuse of electrolyte testing. Pre- and post-intervention comparisons were made.

The researchers found that the mean baseline rate of electrolyte testing was 2.0 laboratory draws per 10 patient days. This rate decreased by 35 percent one month following the initial educational interventions to 1.3 electrolyte laboratory draws per 10 patient days. This decrease has been sustained for nine months, saving an estimated $292,000 in patient-level charges over the course of a year. For the highest-charge electrolyte panel, use decreased from 67 to 22 percent of testing. There have been no changes in rates of medical emergency team calls or readmission.

"Our improvement intervention was associated with significant and rapid reduction in electrolyte testing and has not been associated with unintended adverse events," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »